Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Twice-daily dosing"'
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 6, Iss 1, Pp 76-82 (2017)
Purpose: To compare the pharmacokinetic profile, clinical efficacy and toxicity of once-daily dosing of amikacin compared to twice-daily dosing among pediatric cancer patients with fever and neutropenia. Methods: 134 pediatric patients with hematolog
Externí odkaz:
https://doaj.org/article/4ba20d291df74155b2e9bec3456150a7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma
Autor:
Lucy Liu, Ying C. Ou, Srikumar Sahasranaman, William Novotny, Yuying Gao, Zhiyu Tang, Aileen Cohen, Kun Wang
Publikováno v:
Leukemia & Lymphoma. 62:2612-2624
This report summarizes a totality-of-evidence approach supporting recommendation of a 320-mg total daily dose, either as 160-mg twice daily (BID) or 320-mg once daily (QD) for zanubrutinib in patients with mantle cell lymphoma. Data were derived from
Autor:
Mark Gilchrist, Michael Charles Allwood, Laima Ozolina, R Andrew Seaton, Felicity Drummond, Conor Jamieson, Tim Hills, Mark Santillo, Alan-Shaun Wilkinson
Publikováno v:
JAC-Antimicrobial Resistance
Objectives To investigate the stability of ceftolozane/tazobactam 5 mg/mL and 20 mg/mL solutions for infusion in two elastomeric devices: FOLFusor LV10 (Baxter Healthcare) and Easypump® II (B. Braun Medical Ltd) and determine if an extended shelf li
Autor:
Kyle Fischer, Sandy Diec
Publikováno v:
Cureus
This review aimed to assess the efficacy and safety of once- versus twice-daily administration of angiotensin-converting enzyme (ACE) inhibitors for the management of hypertension. A literature search on PubMed and Google Scholar was performed (Janua
Autor:
Eleanor Best
Publikováno v:
Veterinary Evidence, Vol 6, Iss 3 (2021)
PICO question In reducing surgical recovery time in rabbits (Oryctolagus cuniculus), should doses exceeding 0.2 mg/kg of oral meloxicam be given and is twice daily administration more effective than a single daily dose? Clinical bottom line Category
Autor:
Jeff Zhao, Anita Kohli, Daou Nadine, Stephen A. Harrison, Margaret J. Koziel, Ziad Younes, Nadege Gunn, Rashmee Patil, Seth J. Baum, Manu V. Chakravarthy, Michael Hamill, Juan P. Frias
Publikováno v:
Diabetes. 70
Background: AXA1125, an investigational composition of 5 amino acids and n-acetyl-cysteine, targets multiple biologies relevant to NAFLD pathogenesis. Methods: Primary human hepatocytes (PHH) from multiple donors were pretreated with AXA1125 componen
Autor:
Rajesh Sinha, Manpreet Kaur, Thirumurthy Velpandian, Jeewan S Titiyal, Pradeep Venkatesh, Rajeswari Thangavel
Publikováno v:
Journal of cataract and refractive surgery. 47(9)
PURPOSE To evaluate aqueous pharmacokinetics of topical bromfenac 0.09% and compare clinical outcomes of once- and twice-daily dosing in phacoemulsification. SETTING Dr. R.P. Center for Ophthalmic Sciences, AIIMS, New Delhi, India. DESIGN Prospective
Autor:
Latika Rohilla, Devi Dayal
Publikováno v:
Pediatric Endocrinology Diabetes and Metabolism. 25:103-105
Autor:
Robert L. Bacallao, Ying-Hua Cheng, Kimberly S. Collins, Takashi Hato, Tarek M. El-Achkar, Todd C. Skaar, Pierre C. Dagher, Thomas De Luca, Michael T. Eadon, Joseph Ipe, Eric A. Benson
Publikováno v:
Journal of Drug Delivery
Journal of Drug Delivery, Vol 2017 (2017)
Journal of Drug Delivery, Vol 2017 (2017)
siRNA stabilized for in vivo applications is filtered and reabsorbed in the renal proximal tubule (PT), reducing mRNA expression transiently. Prior siRNA efforts have successfully prevented upregulation of mRNA in response to injury. We proposed redu